← Leaderboards
Justin Pierce Annes
Brigham And Women'S Hospital
$9,382,725
Attributed
$9,991,088
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,991,088 · 7
By mechanism
R01$5,896,278 · 2
U01$1,476,435 · 1
T32$1,216,727 · 1
K08$787,503 · 1
P30$457,145 · 1
R03$157,000 · 1
Top collaborators
- David Matthew Maahs8 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Caitlin C O'Meara$3,294,299
- Vinay Subhash Mahajan$2,281,884
- Murugaiyan Gopal$7,662,393
- Sarah S Grant$549,180
- James W Mier$3,282,868
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusBeta CellIsletIn VitroInsulinPreventIn VivoRegenerativeNatural RegenerationInterestScreeningSmall MoleculeInnovationBlood Glucose RegulationCellsFunctional DisorderMolecularNon-Insulin-Dependent Diabetes MellitusMeetingsAmericanGenesBaseOralMetabolic
Grant awards (37)
Developing A Platform Technology For β-Cell-Targeted Drug Delivery$486,658
U01 · FY2025 · DK · contact PI
Diabetes, Endocrinology and Metabolism Training Grant$348,807
T32 · FY2025 · DK · contact PI
Diabetes, Endocrinology and Metabolism Training Grant$36,221
T32 · FY2025 · DK · contact PI
Leveraging the Uniquely High Beta-Cell Zinc Content for Targeted Drug Delivery$491,978
R01 · FY2024 · DK · contact PI
Developing A Platform Technology For β-Cell-Targeted Drug Delivery$433,592
U01 · FY2024 · DK · contact PI
Diabetes, Endocrinology and Metabolism Training Grant$295,665
T32 · FY2024 · DK · contact PI
Diabetes, Endocrinology and Metabolism Training Grant$91,953
T32 · FY2024 · DK · contact PI
Diabetes, Endocrinology and Metabolism Training Grant$35,612
T32 · FY2024 · DK · contact PI
Developing A Platform Technology For β-Cell-Targeted Drug Delivery$556,185
U01 · FY2023 · DK · contact PI
Leveraging the Uniquely High Beta-Cell Zinc Content for Targeted Drug Delivery$481,355
R01 · FY2023 · DK · contact PI
Development of Beta-Cell-Targeted Regenerative Therapeutics Using A Novel Prodrug Strategy$426,790
R01 · FY2023 · DK · contact PI
Diabetes, Endocrinology and Metabolism Training Grant$290,985
T32 · FY2023 · DK · contact PI
Diabetes, Endocrinology and Metabolism Training Grant$83,254
T32 · FY2023 · DK · contact PI
Diabetes, Endocrinology and Metabolism Training Grant$34,230
T32 · FY2023 · DK · contact PI
Leveraging the Uniquely High Beta-Cell Zinc Content for Targeted Drug Delivery$440,959
R01 · FY2022 · DK · contact PI
Development of Beta-Cell-Targeted Regenerative Therapeutics Using A Novel Prodrug Strategy$426,790
R01 · FY2022 · DK · contact PI
Leveraging the Uniquely High Beta-Cell Zinc Content for Targeted Drug Delivery$436,174
R01 · FY2021 · DK · contact PI
Development of Beta-Cell-Targeted Regenerative Therapeutics Using A Novel Prodrug Strategy$426,790
R01 · FY2021 · DK · contact PI
Enrichment Program$91,429
P30 · FY2021 · DK · contact PI
Development of Beta-Cell-Targeted Regenerative Therapeutics Using A Novel Prodrug Strategy$426,790
R01 · FY2020 · DK · contact PI
Enrichment Program$91,429
P30 · FY2020 · DK · contact PI
Development of Beta-Cell-Targeted Regenerative Therapeutics Using A Novel Prodrug Strategy$426,790
R01 · FY2019 · DK · contact PI
The Role of Adenosine Kinase in Controlling Beta-Cell Regeneration$371,577
R01 · FY2019 · DK · contact PI
Enrichment Program$91,429
P30 · FY2019 · DK · contact PI
The Role of Adenosine Kinase in Controlling Beta-Cell Regeneration$381,363
R01 · FY2018 · DK · contact PI
Enrichment Program$91,429
P30 · FY2018 · DK · contact PI
The Role of Adenosine Kinase in Controlling Beta-Cell Regeneration$381,725
R01 · FY2017 · DK · contact PI
Enrichment Program$91,429
P30 · FY2017 · DK · contact PI
The Role of Adenosine Kinase in Controlling Beta-Cell Regeneration$380,467
R01 · FY2016 · DK · contact PI
The Role of Adenosine Kinase in Controlling Beta-Cell Regeneration$396,730
R01 · FY2015 · DK · contact PI
Interrogating the Role of Adenosine Kinase in Islet Beta-Cells$78,500
R03 · FY2014 · DK · contact PI
Pancreatic Beta-Cell Regeneration: Expanding the functional Mass$153,749
K08 · FY2013 · DK · contact PI
Interrogating the Role of Adenosine Kinase in Islet Beta-Cells$78,500
R03 · FY2013 · DK · contact PI
Pancreatic Beta-Cell Regeneration: Expanding the functional Mass$153,749
K08 · FY2012 · DK · contact PI
Pancreatic Beta-Cell Regeneration: Expanding the functional Mass$161,065
K08 · FY2011 · DK · contact PI
Pancreatic Beta-Cell Regeneration: Expanding the functional Mass$159,991
K08 · FY2010 · DK · contact PI
Pancreatic Beta-Cell Regeneration: Expanding the functional Mass$158,949
K08 · FY2009 · DK · contact PI